EUVIMEDEUVIMED entdecken
Crossref

Clinical outcomes of adaptive intracavitary and interstitial brachytherapy technique in locally advanced cervical cancer: A real-world data

Sheetal R Kashid, Lavanya Gurram, Saritha Pullan, Supriya Chopra, Prachi Mittal, Yogesh Ghadi, A Dheera, Libin Scaria, Satish Kohle, Sudarshan Kadam, Jaya Ghosh, Sushmita Rath und 2 weitere

Brachytherapy · 2024-07 · 23 (4) · 407-415

DOI: 10.1016/j.brachy.2024.03.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brachytherapy, 2024-07. Verfasst von Sheetal R Kashid und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Parel, Mumbai, Maharashtra, India. Hauptthemen laut MEDLINE: Brachytherapy, Uterine Cervical Neoplasms, Radiotherapy Dosage. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To evaluate clinical outcomes of CT-based adaptive intracavitary and interstitial brachytherapy (IC followed by IC-ISBT) in locally advanced cervical cancer (LACC) in resource-constrained settings. METHODS AND MATERIALS: LACC patients treated with adaptive brachytherapy techniques were analyzed to evaluate treatment characteristics and clinical outcomes. The Kaplan-Meier method was used for survival analysis, and the log-rank test for univariate analysis. RESULTS: Out of 141 eligible patients with LACC, 87 (61.7%) patients received external beam radiotherapy (EBRT) in referral hospitals, while 54 (38.3%) were treated at our center. We divided our cohort into two groups: poor EBRT responder group (n = 70 [49.6%]) where IC-ISBT was adapted to achieve optimum tumor doses and OAR optimization group 71 (50.4%) where IC-ISBT was performed to reduce OAR doses. Median HRCTV-D90 dose was 88 Gy (range 70-109 Gy) with median HRCTV volume 33cc (range 15-96). Median D2cc doses to OARs were 90 Gy (range 70-107), 71 Gy (range 55-105) and 70 Gy (range 47-90) to bladder, rectum and sigmoid, respectively. At median follow-up of 32 months, 3-year local control (LC), locoregional control (LRC), disease-free survival (DFS) and overall survival (OS) were 83%, 75%, 64% and 72%, respectively. Subgroup analysis revealed significantly better outcomes for OAR optimization compared to poor EBRT responders, with 3-year LC (95% vs. 70.1%, p < 0.001), LRC (87.3% vs. 62.7%, p < 0.001), DFS (79.2% vs. 49.4%, p < 0.001), and OS (86.2% vs. 57.4%, p < 0.001) CONCLUSION: In resource-constrained settings, implementation of Adaptive IC-ISBT is a viable alternative for optimizing OAR doses in LACC. However proactive approach employing IC-ISBT for tumor dose-escalation from first fraction of BT is warranted for improving LC in poor EBRT responders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrachytherapyUterine Cervical NeoplasmsRadiotherapy DosageHumansFemaleMiddle AgedAgedAdultTreatment OutcomeAged, 80 and overRetrospective StudiesTomography, X-Ray ComputedOrgans at Risk

Stichwörter der Autor:innen

Adaptive brachytherapyBrachytherapyCervical cancerHDR

Autor:innen und Institutionen

  • Department of Radiation Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Parel, Mumbai, Maharashtra, India.
  • Advanced Radiation Oncology Fellow, Department of Radiation Oncology, CancerCare Manitoba, Canada. Electronic address: naidu.lavanya@gmail.com.
  • Department of Radiation Physics, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Parel, Mumbai, Maharashtra, India.
  • Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Parel, Mumbai, Maharashtra, India.
  • Homi Bhabha Cancer Hospital, Visakhapatnam, Tata Memorial Centre, Homi Bhabha National Institute, Parel, Mumbai, Maharashtra, India.

Zitieren

APA

Kashid, S. R., Gurram, L., Pullan, S., Chopra, S., Mittal, P., Ghadi, Y., Dheera, A., Scaria, L., Kohle, S., Kadam, S., Ghosh, J., Rath, S., Gupta, S., & Mahantshetty, U. (2024). Clinical outcomes of adaptive intracavitary and interstitial brachytherapy technique in locally advanced cervical cancer: A real-world data. Brachytherapy, 23(4), 407-415. https://doi.org/10.1016/j.brachy.2024.03.006

Vancouver

Kashid SR, Gurram L, Pullan S, Chopra S, Mittal P, Ghadi Y, et al. Clinical outcomes of adaptive intracavitary and interstitial brachytherapy technique in locally advanced cervical cancer: A real-world data. Brachytherapy. 2024;23(4):407-415. doi:10.1016/j.brachy.2024.03.006

BibTeX
@article{Kashid2024,
  author = {Kashid, Sheetal R and Gurram, Lavanya and Pullan, Saritha and Chopra, Supriya and Mittal, Prachi and Ghadi, Yogesh and Dheera, A and Scaria, Libin and Kohle, Satish and Kadam, Sudarshan and Ghosh, Jaya and Rath, Sushmita and Gupta, Sudeep and Mahantshetty, Umesh},
  title = {Clinical outcomes of adaptive intracavitary and interstitial brachytherapy technique in locally advanced cervical cancer: A real-world data},
  journal = {Brachytherapy},
  year = {2024},
  volume = {23},
  number = {4},
  pages = {407--415},
  doi = {10.1016/j.brachy.2024.03.006}
}
Kostenlos starten →